Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

Bluestem Biosciences raises $5 million for chemical fermentation

by Matt Blois
August 14, 2022 | A version of this story appeared in Volume 100, Issue 28

 

Bluestem Biosciences, a synthetic biology start-up, has raised $5 million in seed financing to pursue the production of chemicals via anaerobic fermentation. The company told the trade group Bio Nebraska it plans to license yeast strains and fermentation processes to companies that own fermentation infrastructure. Bluestem will use computational tools to develop a product pipeline. The company’s team includes alumni from synthetic biology companies such as Ginkgo Bioworks, Zymergen, and Amyris.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.